Black Rock Inc. Spring Works Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,619,260 shares of SWTX stock, worth $303 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,619,260
Previous 5,438,857
3.32%
Holding current value
$303 Million
Previous $268 Million
20.93%
% of portfolio
0.0%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding SWTX
# of Institutions
241Shares Held
69.7MCall Options Held
144KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA6.71MShares$363 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.84MShares$208 Million4.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$190 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$185 Million5.82% of portfolio
-
State Street Corp Boston, MA3.09MShares$167 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $3.37B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...